Home > Insider Trading > Filing (0001144204-14-008841)

Filing Details

Accession Number:: 0001144204-14-008841
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-13 21:37:17
Reporting Period:: 2006-06-07

Filing Date:: 2014-02-13
Accepted Time:: 2014-02-13 21:37:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1335103	Protea Biosciences Group Inc.	NONE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1529510	C Stephen Turner	955 Hartman Run Road Morgantown WV 26507	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-30	224,204	$112,102.00	2,153,372	No	4	P	Direct
Common Stock	Acquisiton	2013-07-30	224,204	$112,102.00	2,153,372	No	4	P	Indirect	Jointly held with wife, Nancy Turner

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	Jointly held with wife, Nancy Turner

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Acquisiton	2006-06-07	100,000	$80,000.00	100,000	$0.80
Common Stock	Stock Option	Acquisiton	2010-04-23	240,625	$360,938.00	240,625	$1.50
Common Stock	Convertible Note	Acquisiton	2012-04-16	200,000	$100,000.00	0	$0.50
Common Stock	Convertible Note	Acquisiton	2012-04-16	200,000	$100,000.00	0	$0.50
Common Stock	Convertible Note	Acquisiton	2012-09-25	40,000	$20,000.00	0	$0.50
Common Stock	Convertible Note	Acquisiton	2012-09-25	40,000	$20,000.00	0	$0.50
Common Stock	Warrant	Acquisiton	2013-07-29	168,153	$184,968.00	0	$1.10
Common Stock	Warrant	Acquisiton	2013-07-29	168,153	$184,968.00	0	$1.10
Common Stock	Convertible Note	Disposition	2013-07-30	224,204	$112,102.00	0	$0.50
Common Stock	Convertible Note	Disposition	2013-07-30	224,204	$112,102.00	0	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
216,668	2006-06-07	2016-06-07	No	4	A	Direct
457,293	2010-04-23	2020-04-23	No	4	A	Direct
657,293	2012-04-16	2013-05-31	No	4	P	Direct
657,293	2012-04-16	2013-05-31	No	4	P	Indirect
697,293	2012-09-25	2013-12-31	No	4	P	Direct
697,293	2012-09-25	2013-12-31	No	4	P	Indirect
865,446	2018-07-29	2018-07-29	No	4	P	Direct
865,446	2018-07-29	2018-07-29	No	4	P	Indirect
508,778	2013-07-30	2013-07-30	No	4	C	Direct
508,778	2013-07-30	2013-07-30	No	4	C	Indirect

Footnotes

On April 16, 2012, the company issued to Stephen Turner's wife, Nancy Turner, a promissory noted in the principal amount of $100,000 to accrue simple interest at the rate of ten percent (10%) per annum (the "April Note"). The April Note accrues simple interest at 10% per annum and was initially convertibleed into shares of common stock at $2.00 per share. On March 22, 2013, the board of directors of the Company agreed to reduce the conversion rate of the April Note to $0.50 per share. The April Note was converted into shares of common stock of the Company in accordance with the Conversion Agreement described below on June 30, 2013. Nancy Turner converted the outstanding principal and interest due and payable on the April Note and the September Note equal to $112,102 into 224,204 shares of common stock.
Represents the securities of the Company owned of record jointly by Stephen Turner and his wife, Nancy Turner.
On September 25, 2012, the company issued a convertible promissory note to Stephen and Nancy Turner in the principal amount of $20,000 (the "September Note") The September Note was initially convertible into shares of common stock of the Company at a conversion rate of $2.00 per share. On March 22, 2013, the board of directors of the Company agreed to reduce the conversion rate of the April Note to $0.50 per share. On June 30, 2013, pursuant to the terms and conditions of a Conversion Agreement, dated June 18, 2013 (the "Conversion Agreement")
Pursuant to the Conversion Agreement, upon conversion of the April Note and the September Note, the Company agreed to issue a five-year warrant to purchase 75% of the number of shares into which the April Note and the September Note were collectively convertible into.
Represents warrants to purchase up to 284,821 shares of common stock jointly held by Stephen Turner and Nancy Turner and 300,000 shares of common stock to be acquired upon the exercise of stock options.
Represents shares vested as of February 10, 2014.
Reflects the expiration of previously reported warrants to purchase 116,668 shares of common stock held by the Reporting Person.